Candida colonization in orthotopic liver transplantation

Fluconazole versus oral amphotericin B

A. M. Tortorano, M. A. Viviani, A. Pagano, G. Paone, B. Gridelli, G. Breda, M. Langer

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Liver transplant recipients are at high risk for invasive candidosis due to the elevated rate of Candida colonization. With the aim of identifying an effective prophylaxis, a randomized 3-year study was conducted on 75 liver transplanted patients in the Liver Transplantation Department of the University of Milan to compare the efficacy of intravenous/oral fluconazole (200 mg/day) versus oral amphotericin B (6,000 mg/day). Patients were randomized to one of the two antifungal prophylaxis protocols during the transplant operation. Mycological surveillance was performed on alternate days during the 4 weeks of prophylaxis. At the time of transplant Candida colonization was detected in 21/34 evaluable patients allocated to amphotericin B and 20/38 allocated to fluconazole. Candida albicans was the most frequently isolated species (detected in 17 and 11 patients in the amphotericin B and fluconazole groups, respectively). Amphotericin B cleared 12/21 colonizations, including 8 caused by C. albicans, and prevented Candida colonization in 11/13 patients. Fluconazole cured the 11 patients colonized by C. albicans but was ineffective against C. glabrata and C. krusei colonization in 9 cases. Colonization was prevented by the triazole in all 18 patients whose mucous membranes were not colonized at the time of transplant. Both antifungals were safe and well tolerated and no interaction with cyclosporin A was evident during fluconazole treatment. Fluconazole seems the antifungal of choice for prophylaxis in liver transplant recipients as it proved more effective than oral amphotericin B against C. albicans, which was involved in 70% of colonizations in our series. The disadvantage of its ineffectiveness against C. glabrata and C. krusei may be overcome by mycological surveillance enabling a prompt change of antifungal in presence of colonization by these species. In addition, administration of the triazole (once daily, intravenously/orally) is more convenient than that of amphotericin B (every 6 hours, per os and by nasogastric tube, if present).

Original languageEnglish
Pages (from-to)21-24
Number of pages4
JournalJournal de Mycologie Medicale
Volume5
Issue number1
Publication statusPublished - 1995

Fingerprint

liver transplant
fluconazole
Fluconazole
amphotericin B
Amphotericin B
Candida
Liver Transplantation
mouth
Candida albicans
disease control
triazoles
Triazoles
Transplants
Liver
Invasive Candidiasis
Candida krusei
Candida glabrata
candidiasis
cyclosporine
monitoring

Keywords

  • Candida colonization
  • fluconazole
  • liver transplantation
  • oral amphotericin B

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Microbiology

Cite this

Tortorano, A. M., Viviani, M. A., Pagano, A., Paone, G., Gridelli, B., Breda, G., & Langer, M. (1995). Candida colonization in orthotopic liver transplantation: Fluconazole versus oral amphotericin B. Journal de Mycologie Medicale, 5(1), 21-24.

Candida colonization in orthotopic liver transplantation : Fluconazole versus oral amphotericin B. / Tortorano, A. M.; Viviani, M. A.; Pagano, A.; Paone, G.; Gridelli, B.; Breda, G.; Langer, M.

In: Journal de Mycologie Medicale, Vol. 5, No. 1, 1995, p. 21-24.

Research output: Contribution to journalArticle

Tortorano, AM, Viviani, MA, Pagano, A, Paone, G, Gridelli, B, Breda, G & Langer, M 1995, 'Candida colonization in orthotopic liver transplantation: Fluconazole versus oral amphotericin B', Journal de Mycologie Medicale, vol. 5, no. 1, pp. 21-24.
Tortorano AM, Viviani MA, Pagano A, Paone G, Gridelli B, Breda G et al. Candida colonization in orthotopic liver transplantation: Fluconazole versus oral amphotericin B. Journal de Mycologie Medicale. 1995;5(1):21-24.
Tortorano, A. M. ; Viviani, M. A. ; Pagano, A. ; Paone, G. ; Gridelli, B. ; Breda, G. ; Langer, M. / Candida colonization in orthotopic liver transplantation : Fluconazole versus oral amphotericin B. In: Journal de Mycologie Medicale. 1995 ; Vol. 5, No. 1. pp. 21-24.
@article{8d9416f75416408789a3eeb03ca7cce2,
title = "Candida colonization in orthotopic liver transplantation: Fluconazole versus oral amphotericin B",
abstract = "Liver transplant recipients are at high risk for invasive candidosis due to the elevated rate of Candida colonization. With the aim of identifying an effective prophylaxis, a randomized 3-year study was conducted on 75 liver transplanted patients in the Liver Transplantation Department of the University of Milan to compare the efficacy of intravenous/oral fluconazole (200 mg/day) versus oral amphotericin B (6,000 mg/day). Patients were randomized to one of the two antifungal prophylaxis protocols during the transplant operation. Mycological surveillance was performed on alternate days during the 4 weeks of prophylaxis. At the time of transplant Candida colonization was detected in 21/34 evaluable patients allocated to amphotericin B and 20/38 allocated to fluconazole. Candida albicans was the most frequently isolated species (detected in 17 and 11 patients in the amphotericin B and fluconazole groups, respectively). Amphotericin B cleared 12/21 colonizations, including 8 caused by C. albicans, and prevented Candida colonization in 11/13 patients. Fluconazole cured the 11 patients colonized by C. albicans but was ineffective against C. glabrata and C. krusei colonization in 9 cases. Colonization was prevented by the triazole in all 18 patients whose mucous membranes were not colonized at the time of transplant. Both antifungals were safe and well tolerated and no interaction with cyclosporin A was evident during fluconazole treatment. Fluconazole seems the antifungal of choice for prophylaxis in liver transplant recipients as it proved more effective than oral amphotericin B against C. albicans, which was involved in 70{\%} of colonizations in our series. The disadvantage of its ineffectiveness against C. glabrata and C. krusei may be overcome by mycological surveillance enabling a prompt change of antifungal in presence of colonization by these species. In addition, administration of the triazole (once daily, intravenously/orally) is more convenient than that of amphotericin B (every 6 hours, per os and by nasogastric tube, if present).",
keywords = "Candida colonization, fluconazole, liver transplantation, oral amphotericin B",
author = "Tortorano, {A. M.} and Viviani, {M. A.} and A. Pagano and G. Paone and B. Gridelli and G. Breda and M. Langer",
year = "1995",
language = "English",
volume = "5",
pages = "21--24",
journal = "Journal de Mycologie Medicale",
issn = "1156-5233",
publisher = "Elsevier Masson",
number = "1",

}

TY - JOUR

T1 - Candida colonization in orthotopic liver transplantation

T2 - Fluconazole versus oral amphotericin B

AU - Tortorano, A. M.

AU - Viviani, M. A.

AU - Pagano, A.

AU - Paone, G.

AU - Gridelli, B.

AU - Breda, G.

AU - Langer, M.

PY - 1995

Y1 - 1995

N2 - Liver transplant recipients are at high risk for invasive candidosis due to the elevated rate of Candida colonization. With the aim of identifying an effective prophylaxis, a randomized 3-year study was conducted on 75 liver transplanted patients in the Liver Transplantation Department of the University of Milan to compare the efficacy of intravenous/oral fluconazole (200 mg/day) versus oral amphotericin B (6,000 mg/day). Patients were randomized to one of the two antifungal prophylaxis protocols during the transplant operation. Mycological surveillance was performed on alternate days during the 4 weeks of prophylaxis. At the time of transplant Candida colonization was detected in 21/34 evaluable patients allocated to amphotericin B and 20/38 allocated to fluconazole. Candida albicans was the most frequently isolated species (detected in 17 and 11 patients in the amphotericin B and fluconazole groups, respectively). Amphotericin B cleared 12/21 colonizations, including 8 caused by C. albicans, and prevented Candida colonization in 11/13 patients. Fluconazole cured the 11 patients colonized by C. albicans but was ineffective against C. glabrata and C. krusei colonization in 9 cases. Colonization was prevented by the triazole in all 18 patients whose mucous membranes were not colonized at the time of transplant. Both antifungals were safe and well tolerated and no interaction with cyclosporin A was evident during fluconazole treatment. Fluconazole seems the antifungal of choice for prophylaxis in liver transplant recipients as it proved more effective than oral amphotericin B against C. albicans, which was involved in 70% of colonizations in our series. The disadvantage of its ineffectiveness against C. glabrata and C. krusei may be overcome by mycological surveillance enabling a prompt change of antifungal in presence of colonization by these species. In addition, administration of the triazole (once daily, intravenously/orally) is more convenient than that of amphotericin B (every 6 hours, per os and by nasogastric tube, if present).

AB - Liver transplant recipients are at high risk for invasive candidosis due to the elevated rate of Candida colonization. With the aim of identifying an effective prophylaxis, a randomized 3-year study was conducted on 75 liver transplanted patients in the Liver Transplantation Department of the University of Milan to compare the efficacy of intravenous/oral fluconazole (200 mg/day) versus oral amphotericin B (6,000 mg/day). Patients were randomized to one of the two antifungal prophylaxis protocols during the transplant operation. Mycological surveillance was performed on alternate days during the 4 weeks of prophylaxis. At the time of transplant Candida colonization was detected in 21/34 evaluable patients allocated to amphotericin B and 20/38 allocated to fluconazole. Candida albicans was the most frequently isolated species (detected in 17 and 11 patients in the amphotericin B and fluconazole groups, respectively). Amphotericin B cleared 12/21 colonizations, including 8 caused by C. albicans, and prevented Candida colonization in 11/13 patients. Fluconazole cured the 11 patients colonized by C. albicans but was ineffective against C. glabrata and C. krusei colonization in 9 cases. Colonization was prevented by the triazole in all 18 patients whose mucous membranes were not colonized at the time of transplant. Both antifungals were safe and well tolerated and no interaction with cyclosporin A was evident during fluconazole treatment. Fluconazole seems the antifungal of choice for prophylaxis in liver transplant recipients as it proved more effective than oral amphotericin B against C. albicans, which was involved in 70% of colonizations in our series. The disadvantage of its ineffectiveness against C. glabrata and C. krusei may be overcome by mycological surveillance enabling a prompt change of antifungal in presence of colonization by these species. In addition, administration of the triazole (once daily, intravenously/orally) is more convenient than that of amphotericin B (every 6 hours, per os and by nasogastric tube, if present).

KW - Candida colonization

KW - fluconazole

KW - liver transplantation

KW - oral amphotericin B

UR - http://www.scopus.com/inward/record.url?scp=0028955761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028955761&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 21

EP - 24

JO - Journal de Mycologie Medicale

JF - Journal de Mycologie Medicale

SN - 1156-5233

IS - 1

ER -